Data Dictionary: Belgian Cancer Registry: Difference between revisions
From Beacon
(Created page with "Source: [https://kankerregister.org/media/docs/downloads/applications/ManuelWBCRv2.1.pdf] {| class="wikitable" ! Patient's information |- ! Variables |- | Hospital |- | Patients' social security number |- | Name |- | Postal code |- | Town |- | Country |- | Number of the insurer |- | Birth date |- | Date of death |- | Sex |} {| class="wikitable" ! Diagnosis |- ! Variables |- | Incidence date |- | Diagnostic method |- | OMS score of the diagnosis |- | Localization of the...") |
m (Update categories.) |
||
| (18 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
<span style="display:none">forresearchers</span> <span style="display:none">belgiumcountry</span> | |||
Go back to [[Belgium]] page | |||
Sources - Cancer Diagnosis Variables: [https://kankerregister.org/nl/kankerdiagnoses Click here to learn more]; Screening Variables: [https://kankerregister.org/nl/screening Click here to learn more]. | |||
'''Table 1:''' Cancer Diagnosis Variables. | |||
{| class="wikitable" | {| class="wikitable" | ||
|- | |- | ||
| Unique patient identification including demographic parameters (i.e., date of birth, zip code) | |||
|- | |- | ||
| | | Unique identification of the care program and hospital | ||
|- | |- | ||
| | | Diagnosis according to international classification | ||
|- | |- | ||
| | | Date of incidence | ||
|- | |- | ||
| | | Tumour stage (cTNM) | ||
|- | |- | ||
| | | Conclusion of the pathological report (including pTNM) | ||
|- | |- | ||
| | | Treatment with reference to guidelines or justification of deviation | ||
|- | |- | ||
| | | Follow-up plan | ||
|- | |- | ||
| | | Side effects | ||
|- | |- | ||
| | | Disease-free survival and survival (i.e., treatment outcome) | ||
|- | |- | ||
| | | Date of death | ||
|- | |- | ||
| Gender | |||
|- | |- | ||
| | | Region | ||
|- | |- | ||
| | | Incidence year | ||
|- | |- | ||
| | | 5-year age group (only for absolute numbers and gross incidence) | ||
| | |} | ||
'''Table 2:''' Screening Variables. | |||
{| class="wikitable" | |||
| | |||
|- | |- | ||
| | | Aspects of Participation and Screening Test Usage | ||
|- | |- | ||
| | | Aspects of participation | ||
|- | |- | ||
| | | Use of the screening test in the target group | ||
|- | |- | ||
| | | Results obtained and their use (including cancer detection rate, sensitivity, and specificity) | ||
|- | |- | ||
| | | Cyto-histopathology register | ||
|- | |- | ||
| | | Results of further follow-up | ||
|} | |} | ||
Latest revision as of 13:25, 2 December 2025
Go back to Belgium page
Sources - Cancer Diagnosis Variables: Click here to learn more; Screening Variables: Click here to learn more.
Table 1: Cancer Diagnosis Variables.
| Unique patient identification including demographic parameters (i.e., date of birth, zip code) |
| Unique identification of the care program and hospital |
| Diagnosis according to international classification |
| Date of incidence |
| Tumour stage (cTNM) |
| Conclusion of the pathological report (including pTNM) |
| Treatment with reference to guidelines or justification of deviation |
| Follow-up plan |
| Side effects |
| Disease-free survival and survival (i.e., treatment outcome) |
| Date of death |
| Gender |
| Region |
| Incidence year |
| 5-year age group (only for absolute numbers and gross incidence) |
Table 2: Screening Variables.
| Aspects of Participation and Screening Test Usage |
| Aspects of participation |
| Use of the screening test in the target group |
| Results obtained and their use (including cancer detection rate, sensitivity, and specificity) |
| Cyto-histopathology register |
| Results of further follow-up |
